Category: Life Sciences

In recent years, cloud technology has been embraced as an enabler of value creation, helping improve enterprise resilience, innovation speed and scalability without the need for large capital expenditures and even reducing ongoing operational costs. Fortune 500 pharma and MedTech companies could gain by 2030, $10-15 billion in improved EBITDA run rates and $25-30 billion […]

U.S. policymakers have increasingly embraced the promise of cloud to discover new cures, accelerate biomedical innovation, and spur development of life-saving medical technologies. With the growing adoption of the cloud in life sciences, cloud use can help product developers and regulators get data more quickly and enable manufacturers to meet and exceed their compliance requirements. […]

Like businesses in any other industry, pharmaceutical companies compete with each other. Despite their individual races to the finish line, the mission is the same: develop and produce lifesaving and life-changing treatments that move medicine, and humanity, forward. The recognition of this mutual goal, and the potential of breaking down siloes to share information, has […]

Retrieving, processing, and analyzing electronic lab notebook (ELN) data is slow, costly, and labor intensive. AWS storage, databases, and artificial intelligence/machine learning services can significantly enhance knowledge retrieval speed, unlock unstructured ELN assets, facilitate building knowledge graphs, and form scalable and cost-effective processing pipelines. Introduction ELN is computer software heavily used in research settings (especially […]

Blog is guest authored by Chong Duan, Amey Kelekar, and Mary Kate Montgomery from Pfizer Echocardiography (echo) is an ultrasound-based, non-invasive imaging modality. Manual analysis of echo data is time consuming and susceptible to inter-reader variability. Pfizer has developed a fully automated analysis framework that significantly reduced analysis time by more than 92% using Amazon […]

re:Invent is an opportunity to dive into innovative technologies and explore new ideas, and for healthcare and life sciences (HCLS) organizations, it is the time to think about how to reinvent collaborations, improve data driven decision making, and drive new discoveries, all with the goal of improving patient outcomes. At re:Invent 2022, we continued our […]

Amazon Omics is a new fully managed service which helps AWS customers store, query, analyze, and generate insights from genomic, transcriptomic, and other omics data to improve health and accelerate scientific discoveries. Many AWS customers want to go faster in their migration to the cloud, and the good news is that Amazon Omics has broad support […]

We would like to acknowledge the valuable contributions of David Obenshain, Gargi Singh Chhatwal, and Joshua Broyde, who are Solutions Architects at AWS. With the rapid advancement and use of Genomic sequencing within research and clinical organizations, we need reliable, reproducible, scalable, and cost-efficient infrastructure to manage data and compute resources. Organizations want to spend […]

This is the first installation of a two-part series detailing the launch of Amazon Omics. The second installation provides deeper technical details. We are excited to launch the general availability of Amazon Omics–a purpose-built service that will help bioinformaticians, researchers, and scientists store, query, analyze, and generate insights from genomic, transcriptomic, and other omics data. […]

Blog is guest authored by Nitin Kaul and Guglielmo Iozzia of Merck & Co., Inc. Improving the productivity of manufacturing operations is vital for pharmaceutical companies, so patients can get the critical medicines they need, faster. While patient safety has always been the highest priority, Merck & Co., Inc. (MSD), the leading global biopharmaceutical company, […]